The Compound <i>(E)</i>-2-Cyano-<i>N</i>,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases
The compound <i>(E)</i>-2-cyano-<i>N</i>,3-diphenylacrylamide (JMPR-01) was structurally developed using bioisosteric modifications of a hybrid prototype as formed from fragments of indomethacin and paracetamol. Initially, in vitro assays were performed to determine cell viab...
Main Authors: | Pablo Rayff da Silva, Renan Fernandes do Espírito Santo, Camila de Oliveira Melo, Fábio Emanuel Pachú Cavalcante, Thássia Borges Costa, Yasmim Vilarim Barbosa, Yvnni M. S. de Medeiros e Silva, Natália Ferreira de Sousa, Cristiane Flora Villarreal, Ricardo Olímpio de Moura, Vanda Lucia dos Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/1/188 |
Similar Items
-
Bioisosterism of Fluorine and Cyano as Indole Substituents. Theoretical, in vitro and in vivo Examination
by: Timo Heinrich, et al.
Published: (2004-03-01) -
<i>O</i>-((Ferrocenyl)(3-fluorophenyl)methyl)hydroxylamine
by: Angeliki S. Foscolos, et al.
Published: (2022-03-01) -
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents
by: Matteo Mori, et al.
Published: (2021-02-01) -
BDSF Analogues Inhibit Quorum Sensing-Regulated Biofilm Production in <i>Xylella fastidiosa</i>
by: Conor Horgan, et al.
Published: (2024-12-01) -
2-Aminothiophene Derivatives—New Drug Candidates Against Leishmaniasis: Drug Design, Synthesis, Pharmacomodulation, and Antileishmanial Activity
by: Rodrigo Santos Aquino de Araújo, et al.
Published: (2025-01-01)